(Booth 6617) Nemoto Kyorindo of Tokyo will display new functionality for its Nemoto Dual Shot Alpha contrast injector system, including a new body-weight protocol.
The feature provides a means of setting injection protocols based on a patient's weight to provide consistent levels of iodine over the injection period. Distributed exclusively through GE Healthcare of Chalfont St. Giles, U.K., this feature was released in Japan in 2000 and the rest of Asia and Europe in 2008.
In addition, Nemoto will display as a work-in-progress an extravasation detection product with a very small sensor that can be used with any intravenous injection apparatus. The device has not been cleared by the U.S. Food and Drug Administration, and a launch date has not yet been determined.
![Images show the pectoralis muscles of a healthy male individual who never smoked (age, 66 years; height, 178 cm; body mass index [BMI, calculated as weight in kilograms divided by height in meters squared], 28.4; number of cigarette pack-years, 0; forced expiratory volume in 1 second [FEV1], 97.6% predicted; FEV1: forced vital capacity [FVC] ratio, 0.71; pectoralis muscle area [PMA], 59.4 cm2; pectoralis muscle volume [PMV], 764 cm3) and a male individual with a smoking history and chronic obstructive pulmonary disorder (COPD) (age, 66 years; height, 178 cm; BMI, 27.5; number of cigarette pack-years, 43.2, FEV1, 48% predicted; FEV1:FVC, 0.56; PMA, 35 cm2; PMV, 480.8 cm3) from the Canadian Cohort Obstructive Lung Disease (i.e., CanCOLD) study. The CT image is shown in the axial plane. The PMV is automatically extracted using the developed deep learning model and overlayed onto the lungs for visual clarity.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/03/genkin.25LqljVF0y.jpg?auto=format%2Ccompress&crop=focalpoint&dpr=2&fit=crop&h=167&q=70&w=250)
